Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function Source: Eur Respir J 2006; 28: Suppl. 50, 278s Year: 2006
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006
Effect of baseline FVC on lung function decline with nintedanib in patients with IPF Source: International Congress 2015 – Treatment of IPF Year: 2015
Predicted postoperative FEV1, DLCO and VO2 underestimate the postoperative values after lung resection in patients with symptomatic non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015
The effect of exercise in the patients with the diagnosis of interstitial lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 372s Year: 2006
Roles of transthoracic lung ultrasonography in diagnosis of interstitial lung disease: correlation with HRCT, vital capacity, diffusing of the lung for monoxide test Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS Source: Eur Respir J, 54 (4) 1802214; 10.1183/13993003.02214-2018 Year: 2019
Lung volumes, diffusing capacity and static lung compliance in patients with UIP pattern of IPF Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002
Bronchectasis in COPD: relation of bronchial and parenchymal lesions in HRCT to the clinical and functional parameters Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution Year: 2009
The relationship of exacerbations and lung function decline to radiologic characteristics in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019
A progression-free end-point for idiopathic pulmonary fibrosis trials: lessons from cancer Source: Eur Respir J 2013; 41: 262-269 Year: 2013
In active and former smokers with CT detected emphysema but without airway obstruction, the presence of an abnormal DLco is associated with a worse clinical presentation Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008
Features of prediction FEV1 after lobectomy in COPD patients with central or peripheral lung cancer. Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
Lung cancer in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 1216-1219 Year: 2001
Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017